GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $529,000 | -63.4% | 7,769 | -84.3% | 0.07% | -61.3% |
Q4 2021 | $1,444,000 | -14.7% | 49,327 | -25.7% | 0.18% | +5.2% |
Q3 2021 | $1,692,000 | +635.7% | 66,402 | +910.4% | 0.17% | +561.5% |
Q2 2021 | $230,000 | -17.6% | 6,572 | +14.2% | 0.03% | -31.6% |
Q3 2019 | $279,000 | +22.9% | 5,756 | +33.9% | 0.04% | +65.2% |
Q1 2019 | $227,000 | +25.4% | 4,298 | -60.6% | 0.02% | +130.0% |
Q2 2016 | $181,000 | – | 10,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 355,509 | $17,171,000 | 9.58% |
Perceptive Advisors | 4,989,066 | $240,971,000 | 6.75% |
GREAT POINT PARTNERS LLC | 736,631 | $35,579,000,000 | 5.28% |
Casdin Capital, LLC | 600,000 | $28,980,000 | 5.10% |
Avoro Capital Advisors LLC | 1,765,548 | $85,276,000 | 4.07% |
Iguana Healthcare Management, LLC | 115,000 | $5,555,000 | 3.65% |
Camber Capital Management LP | 1,200,000 | $57,960,000 | 2.85% |
NEXTHERA CAPITAL LP | 315,147 | $15,222,000 | 2.51% |
RTW INVESTMENTS, LP | 456,921 | $22,069,000 | 2.10% |
EMORY UNIVERSITY | 41,610 | $2,010,000 | 1.44% |